HONG KONG (Reuters) - Experts on the H5N1 bird flu virus are divided on how to treat patients infected by the virus, which kills 60 percent of its victims.
In an article published in PLoS Medicine, Nicholas White at Mahidol University in Thailand argued that higher doses of the drug Tamiflu should be used to fight more resistant strains of the virus, but researchers in the United States said that would result in the virus becoming resistant.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!